chr8-27823203-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_018492.4(PBK):c.155C>T(p.Ser52Phe) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000134 in 1,488,200 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 7.5e-7 ( 0 hom. )
Consequence
PBK
NM_018492.4 missense, splice_region
NM_018492.4 missense, splice_region
Scores
4
10
5
Clinical Significance
Conservation
PhyloP100: 6.70
Genes affected
PBK (HGNC:18282): (PDZ binding kinase) This gene encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. Evidence suggests that mitotic phosphorylation is required for its catalytic activity. The encoded protein may be involved in the activation of lymphoid cells and support testicular functions, with a suggested role in the process of spermatogenesis. Overexpression of this gene has been implicated in tumorigenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PBK | NM_018492.4 | c.155C>T | p.Ser52Phe | missense_variant, splice_region_variant | 4/8 | ENST00000301905.9 | NP_060962.2 | |
PBK | NM_001278945.2 | c.155C>T | p.Ser52Phe | missense_variant, splice_region_variant | 4/8 | NP_001265874.1 | ||
PBK | NM_001363040.2 | c.155C>T | p.Ser52Phe | missense_variant, splice_region_variant | 4/8 | NP_001349969.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PBK | ENST00000301905.9 | c.155C>T | p.Ser52Phe | missense_variant, splice_region_variant | 4/8 | 1 | NM_018492.4 | ENSP00000301905.4 | ||
PBK | ENST00000522944.5 | c.155C>T | p.Ser52Phe | missense_variant, splice_region_variant | 4/8 | 2 | ENSP00000428489.1 | |||
PBK | ENST00000521226.2 | c.53C>T | p.Ser18Phe | missense_variant, splice_region_variant | 4/6 | 3 | ENSP00000427892.2 | |||
PBK | ENST00000524266.1 | n.153-2509C>T | intron_variant | 5 | ENSP00000428438.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151984Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
151984
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 7.48e-7 AC: 1AN: 1336216Hom.: 0 Cov.: 21 AF XY: 0.00000150 AC XY: 1AN XY: 667902
GnomAD4 exome
AF:
AC:
1
AN:
1336216
Hom.:
Cov.:
21
AF XY:
AC XY:
1
AN XY:
667902
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151984Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74222
GnomAD4 genome
AF:
AC:
1
AN:
151984
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74222
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.155C>T (p.S52F) alteration is located in exon 4 (coding exon 3) of the PBK gene. This alteration results from a C to T substitution at nucleotide position 155, causing the serine (S) at amino acid position 52 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
M;M;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;.
REVEL
Uncertain
Sift
Uncertain
D;D;.
Sift4G
Uncertain
D;D;.
Polyphen
D;.;.
Vest4
MutPred
Loss of disorder (P = 0.0065);Loss of disorder (P = 0.0065);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at